PR Newswire NEW YORK, Nov. 11, 2024 NEW YORK, Nov. 11, 2024 /PRNewswire/ -- Report on how AI is driving market transformation - The global healthcare cloud computing market size is estimated to grow by USD 98.6 billion from 2024-2028, ...
PR Newswire GAITHERSBURG, Md., Nov. 11, 2024 GAITHERSBURG, Md., Nov. 11, 2024 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that the U.S. Food and ...
PR Newswire WEXFORD, Pa., Nov. 7, 2024 Study results demonstrate the safety and feasibility of adoptive immunotherapy using allogeneic off-the-shelf NK cells in hospitalized patients with COVID at high risk for progression of disease ...
PR Newswire NEW YORK, Nov. 4, 2024 NEW YORK, Nov. 4, 2024 /PRNewswire/ -- A study conducted by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the Barcelona Institute for Global Health (ISGlobal) ...
PR Newswire BRONX, N.Y., Nov. 1, 2024 BRONX, N.Y., Nov. 1, 2024 /PRNewswire/ -- A new study led by researchers at Albert Einstein College of Medicine involving more than 200,000 adults found that the COVID-19 pandemic caused a 29% increase ...
PR Newswire HOUSTON, Oct. 8, 2024 Healgen Rapid Check® COVID-19/Flu A&B Antigen Test was supported through the Independent Test Assessment Program (ITAP), a National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech ...
PR Newswire SILVER SPRING, Md., Oct. 7, 2024 SILVER SPRING, Md., Oct. 7, 2024 /PRNewswire/ -- Today, the U.S. Food and Drug Administration granted marketing authorization for the Healgen Rapid Check COVID-19/Flu A&B Antigen Test. The test, ...
PR Newswire BOLINGBROOK, Ill., Oct. 3, 2024 Standfirst: Welllife, a Flu home test in addition to COVID-19 BOLINGBROOK, Ill., Oct. 3, 2024 /PRNewswire/ -- WELLlife, a leading innovator in medical diagnostic and testing solutions, is ...
PR Newswire BALDWIN PARK, Calif., Oct. 3, 2024 BALDWIN PARK, Calif., Oct. 3, 2024 /PRNewswire/ -- StemCyte announced today that its Hematopoietic Progenitor Cell Cord Blood therapy (HPC Cord Blood) has officially obtained the Regenerative ...
PR Newswire ROCKVILLE, Md., Oct. 3, 2024 ROCKVILLE, Md., Oct. 3, 2024 /PRNewswire/ -- Expert Systems, a leader in combining human and artificial intelligence to accelerate drug discovery, celebrates a key milestone in the development of ...
Long COVID is draining the economy by billions every year, as workers battle persistent symptoms and face challenges returning to their jobs, reports a new study led by UCL researchers. ...
A new clinical study reveals that an inhibitor of Fas ligand (FasL), also known as CD95 ligand (CD95L), could be the latest game-changing treatment for COVID-19....
Researchers are utilizing AI to detect long COVID symptoms, monitor their progression, and rule out other potential causes. This innovative approach suggests that a substantial 22.8% of the population may be affected by long-term COVID-19 ...
A study led by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the Barcelona Institute for Global Health (ISGlobal) explores public trust in COVID-19 vaccine science and its influence on vaccine acceptance ...
A new study reveals a concerning link between COVID-19 and dyslipidemia. The pandemic led to a 29% increase in dyslipidemia risk, especially among seniors and people with type 2 diabetes. This condition, characterized by abnormal blood lipid levels, significantly elevates the risk of heart attack and stroke. ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers